MEET OUR ADVISORS
Prof. Farzin Farzaneh

Expert in Molecular Medicine and Cell Therapies at King’s College London, whose Cell therapy Unit offers one of the most advanced GMP Cell Production facilities in Europe. Experienced in running GMP facilities for the production of cell and gene therapy based investigational medicinal products since 2001

Professor Farzin Farzaneh

 

Scientific Advisor 

Dr Jonathan Milner

Jonathan Milner, co-founder and currently Deputy Chairman of Abcam plc, is an experienced entrepreneur and investor and is passionate about supporting UK healthcare and high-tech start-ups.  He has provided considerable investment to LIfT BioSciences, and intends to help LIfT BioSciences get N-LIfT to market and to secure a successful exit. Jonathan already helped three tech companies IPO on AIM.

Dr Jonathan Milner

Funding & Growth Advisor

jonathan-milner.jpg
Dr Tony de Fougerolles

Successful Biotech entrepreneur with a strong background in successfully developing and advancing multiple different transformative therapeutic drug platforms in both the nucleic acid and biologics space. In addition, his in-depth expertise in drug development has led to the progression of multiple assets through clinical trials. Prior to joining Evox Therapeutics, Tony was CSO at Ablynx NV and Moderna Therapeutics, and VP Research at Alnylam Pharmaceuticals. PhD in Immunology from Harvard University.

Dr Tony de Fougerolles

Scientific & Partnerships Advisor

Evox_Tony_de_Fougerolles2.jpg
Prof. James Spicer

Professor of Experimental Cancer Medicine, King’s College London, and Consultant in Medical Oncology, Guy’s and St. Thomas’ Hospitals London. He holds a PhD in Cancer Biology from the Institute of Cancer Research in London, and a degree in biochemistry from the University of Oxford. Our Principle Investigator for our planned PoC trial.

Professor James Spicer

Principle Investigator & Clinical Advisor

james-spicer.jpg
Ali Stunt

Founder & CEO of Pancreatic Cancer Action, Founding Board Member and Awareness Group Lead for Pancreatic Cancer Europe. Ali is herself a rare survivor of Pancreatic Cancer.

ali stunt closeup.jpg

Ali Stunt

Patient Interests Advisor

Professor Mark Lowdell

 

Clinical Immunopathologist, Professor of Cell and Tissue Therapy at UCL. Leading pioneer in cell therapies, including co-founding INmune Bio, Achilles Therapeutics, Cell Medica

Professor Mark Lowdell

Scientific & Clinical Advisor